Clinical Trial of Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Against COVID-19
Clinical trial NCT04540419 · COMPLETED
Trial details
- NCT number
- NCT04540419
- Sponsor
- NPO Petrovax
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-11
- Primary completion
- 2021-06-19
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.